-
Mashup Score: 0Genomic Alterations and Self-Reported Agent Orange Exposure in United States Veterans with Metastatic Prostate Cancer - JJ Haijing Zhang - 6 month(s) ago
Andrea Miyahira interviews JJ Haijing Zhang on her research exploring the genomic alterations in prostate cancer patients exposed to Agent Orange. Agent Orange, an herbicide used by the US military during the Vietnam War, is linked to various health toxicities, including prostate cancer. Dr. Zhang’s study aims to identify any specific somatic alterations related to Agent Orange exposure. The…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Addressing Urological Care Challenges in the South - Lorie Fleck - 6 month(s) ago
In a UroToday discussion, Zach Klaassen hosts a conversation with Lorie Fleck about the challenges of providing urological care in the South, the growth of their department at the University of South Alabama, and the importance of training new urologists for underserved areas. Dr. Fleck emphasizes the issues of access and long travel times for patients in remote locations, especially considering…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - Neal D. Shore - 6 month(s) ago
Alicia Morgans engages with Neal Shore about the DEAR study, an analysis of real-world outcomes for non-metastatic castration-resistant prostate cancer (nmCRPC) patients treated with darolutamide, apalutamide, and enzalutamide. The study is made possible by an organization called PPS, which has access to electronic data. It includes information about when patients started their treatments,…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3Genomic Alterations and Self-Reported Agent Orange Exposure in United States Veterans with Metastatic Prostate Cancer - JJ Haijing Zhang - 7 month(s) ago
Andrea Miyahira interviews JJ Haijing Zhang on her research exploring the genomic alterations in prostate cancer patients exposed to Agent Orange. Agent Orange, an herbicide used by the US military during the Vietnam War, is linked to various health toxicities, including prostate cancer. Dr. Zhang’s study aims to identify any specific somatic alterations related to Agent Orange exposure. The…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - Neal D. Shore - 7 month(s) ago
Alicia Morgans engages with Neal Shore about the DEAR study, an analysis of real-world outcomes for non-metastatic castration-resistant prostate cancer (nmCRPC) patients treated with darolutamide, apalutamide, and enzalutamide. The study is made possible by an organization called PPS, which has access to electronic data. It includes information about when patients started their treatments,…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Addressing Urological Care Challenges in the South - Lorie Fleck - 7 month(s) ago
In a UroToday discussion, Zach Klaassen hosts a conversation with Lorie Fleck about the challenges of providing urological care in the South, the growth of their department at the University of South Alabama, and the importance of training new urologists for underserved areas. Dr. Fleck emphasizes the issues of access and long travel times for patients in remote locations, especially considering…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Addressing Urological Care Challenges in the South - Lorie Fleck - 8 month(s) ago
In a UroToday discussion, Zach Klaassen hosts a conversation with Lorie Fleck about the challenges of providing urological care in the South, the growth of their department at the University of South Alabama, and the importance of training new urologists for underserved areas. Dr. Fleck emphasizes the issues of access and long travel times for patients in remote locations, especially considering…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Genomic Alterations and Self-Reported Agent Orange Exposure in United States Veterans with Metastatic Prostate Cancer - JJ Haijing Zhang - 8 month(s) ago
Andrea Miyahira interviews JJ Haijing Zhang on her research exploring the genomic alterations in prostate cancer patients exposed to Agent Orange. Agent Orange, an herbicide used by the US military during the Vietnam War, is linked to various health toxicities, including prostate cancer. Dr. Zhang’s study aims to identify any specific somatic alterations related to Agent Orange exposure. The…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - Neal D. Shore - 9 month(s) ago
Alicia Morgans engages with Neal Shore about the DEAR study, an analysis of real-world outcomes for non-metastatic castration-resistant prostate cancer (nmCRPC) patients treated with darolutamide, apalutamide, and enzalutamide. The study is made possible by an organization called PPS, which has access to electronic data. It includes information about when patients started their treatments,…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Prevalence of Stone Disease and Procedure Trends in the United States - Beyond the Abstract - 9 month(s) ago
stone disease, Prevalence of Stone Disease and Procedure Trends, ureteroscopy, decreasing shockwave lithotripsy, percutaneous nephrolithotomy, stone disease is increasing in Medicare patients.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
Genomic alterations and self-reported #AgentOrange exposure in #UnitedStates #Veterans with metastatic #ProstateCancer. @DrJJZhang @UclaUrology joins @AndreaMiyahira @PCFnews in this discussion of her work on UroToday > https://t.co/CXXHXlrPQs https://t.co/9dTQr6DWuu